Clinical trials are a very important part of the research process. New treatments, medications and medical devices cannot be approved for use in Australia without going through clinical trials. Find out more about clinical trials.

4 results found

Antipsychotic dose reduction to improve recovery and function in young people with psychosis

The REDUCE study is testing whether reducing the dosage of antipsychotic medication of people recovering from their first episode of psychosis can lead to them having better recovery outcomes.

Study in progress

Cannabidiol (CBD) as a potential new treatment for mental ill-health in youths

The Cannabidiol for At Risk Youth (CanARY) study is testing a potential new treatment called cannabidiol (CBD) for helping people with symptoms that might indicate risk of a psychotic disorder. CBD is a non-psychoactive treatment, meaning it does not give you a ‘high’.

Currently recruiting

New treatment for young people with depression

SKY-D is investigating whether ketamine is an effective treatment for young people with depression.

Study completed

Survey for carers of individuals with mental illness

A survey to better understand the experiences of caregivers and siblings of people who have experienced a manic episode or psychosis.

Currently recruiting